Raised levels of apoC1 were also detected in individuals with cardiovascular risk, such as men with metabolic syndrome [127,128], or women, either with polycystic ovarian syndrome [129,130] or post-menopausal with increased body mass index [131]. Here, APOC1 is linked to metabolic syndrome.